BSX
Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 39.80$. Average daily volumn in 3 months 8.95M. Market cap 53.40B
Stock symbol : BSX. Exchange : NYSE. Currency : USD Lastest price : 37.35$. Total volume : 1.89M. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Boston Scientific Corporation (BSX)
Last Price
37.35$Change
0.08Volume
1.89M
| Previous Close | 37.27 |
| Open | 37.22 |
| Day Range | 37.08-37.65 |
| Bid | 37.36 x 800 |
| Ask | 37.38 x 900 |
| Volume | 1.89M |
| Average Volume | 8.95M |
| Market Cap | 53.4B |
| Beta | 0.82 |
| 52 Week Range | 34.98-47.50 |
| Trailing P/E | 70.48 |
| Foward P/E | 18.58 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Market Cap:
53.40BRevenue:
11.89BTotal Assets:
32.23BTotal Cash:
1.93B
News about "Boston Scientific Corporation"
Boston Scientific (NYSE:BSX) Given New $43.00 Price Target at Canaccord Genuity Group
Source from : Defense World - 15 hours ago
Boston Scientific (NYSE:BSX – Get Rating) had its target price cut by stock analysts at Canaccord Genuity Group from $51.00 to $43.00 in a research note issued to investors on Wednesday, Benzinga ...See details»
Boston Scientific Corporation (BSX) Volatility Hits 2.12% – Here’s What An Investor Can Do
Source from : stocksregister - 1 days ago
Boston Scientific Corporation (NYSE:BSX) at last check was buoying at $37.10 on Thursday, June 30, with a fall of -1.85% from its closing price on previous day. Taking a look at stock we notice that ...See details»
Boston Scientific to open Atlanta plant
Source from : The Business Journals - 1 days ago
Boston Scientific’s new plant validates Atlanta's emerging life sciences industry and acts as a catalyst for a suburban town center project.See details»
As a Triple Minority, Shae Finally Feels Seen at Boston Scientific
Source from : CSR Wire - 8 hours ago
Shae Wilson grew up in a military family, bouncing around from California to Japan, and then to North Carolina where her family finally settled and put down roots.See details»
Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results
Source from : YAHOO!Finance - 2 days ago
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ending June 30, 2022 on Wednesday, July 27, 2022 ...See details»
Boston Scientific to open Atlanta plant, latest life sciences win
Source from : The Business Journals - 2 days ago
Boston Scientific’s new plant validates Atlanta's emerging life sciences industry and acts as a catalyst for a suburban town center project.See details»
State of Alaska Department of Revenue Cuts Stock Holdings in Boston Scientific Co. (NYSE:BSX)
Source from : ETF Daily News - 5 days ago
Boston Scientific Company Profile (Get Rating) Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It ...See details»
Boston Scientific To Purchase Majority Stake of M.I.Tech
Source from : medtechintelligence - 9 days ago
M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.” ...See details»
Boston Scientific Remembers Cofounder Pete Nicholas, 1941-2022
Source from : Endovascular Today - 11 days ago
In an extensive online tribute, Boston Scientific Corporation announced the death of Peter M. “Pete” Nicholas, the com ...See details»
Worldwide Surgical Clips Industry to 2027 - Featuring Ackermann Instruments, Boston Scientific and Johnson & Johnson Among Others
Source from : Yahoo Finance - 2 days ago
Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Grena Limited, Johnson & Johnson, LeMaitre Vascula Inc., LocaMed Ltd., Medtronic plc, Meril Life Sciences Pvt.See details»
New Suit - Product Liability
Source from : Law - 10 days ago
Counsel have not yet appeared for the defendant. The case is 6:22-cv-00976, McDermott v. Boston Scientific Corporation.See details»
Tell us: Are you worried about spiked drinks at Boston bars?
Source from : Boston.com - 7 hours ago
Are you concerned about going out in Greater Boston given the reports of spiked drinks? Tell us on Boston.com.See details»
Peripheral Guidewires Market Prognosticated For A Ravishing Growth By 2030 | Abbott Vascular, Boston Scientific Corporation, CONMED Corporation
Source from : Digital Journal - 7 days ago
New Jersey, United States-Peripheral Guidewires Market 2022 – 2030, Size, Share, and Trends Analysis Research Report Segmented with Type, Component, Application, Region, and Forecast Peripheral ...See details»
Spinal Stimulator Market Analysis In-depth Growth Projection with Regional Demand and Revenue Forecast Till 2028 |Boston Scientific Corp., Medtronic
Source from : Digital Journal - 10 days ago
The “Spinal Stimulator Market” Report is an extensive study that focuses on overall consumption patterns, development trends, sales patterns, and sales in key countries of the Spinal ...See details»